Pharmaceutical Executive-03-01-2015

Columns
Pharmaceutical Executive

March 16, 2015

Congress, Obama offer strategies to reduce regulatory roadblocks to new breakthroughs.

Pharmaceutical Executive
From the Editor

March 11, 2015

Pharma jumps on board personal genomics train-at least for test drive-but will journey ultimately help transform treatment or stall out as just another fad?

Pharm Exec profiles patient DNA partnering advocate 23andMe, which recently struck data deals with a pair of big Pharmas, thrusting the debate over personal genomics and patient treatment back into high gear.

Pharmaceutical Executive
Features

March 11, 2015

 

A new PwC survey reveals a strong need to fully embrace alternative commercial methods-not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.

Pharmaceutical Executive

The cholesterol-fighting market is back with a vengeance; plenty of complications in store

Pharmaceutical Executive

New EU group could ultimately end up handcuffing much-needed efforts to modernize drug authorization.

Pharmaceutical Executive
Columns

March 01, 2015

How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality.